Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Host-Targeted Therapeutics against Multidrug Resistant Intracellular Staphylococcus aureus.

Bravo-Santano N, Behrends V, Letek M.

Antibiotics (Basel). 2019 Nov 28;8(4). pii: E241. doi: 10.3390/antibiotics8040241. Review.

2.

Mycoredoxins Are Required for Redox Homeostasis and Intracellular Survival in the Actinobacterial Pathogen Rhodococcus equi.

Mourenza Á, Bravo-Santano N, Pradal I, Gil JA, Mateos LM, Letek M.

Antioxidants (Basel). 2019 Nov 15;8(11). pii: E558. doi: 10.3390/antiox8110558.

3.

Identification of novel targets for host-directed therapeutics against intracellular Staphylococcus aureus.

Bravo-Santano N, Capilla-Lasheras P, Mateos LM, Calle Y, Behrends V, Letek M.

Sci Rep. 2019 Oct 28;9(1):15435. doi: 10.1038/s41598-019-51894-3.

4.

Intracellular Staphylococcus aureus Elicits the Production of Host Very Long-Chain Saturated Fatty Acids with Antimicrobial Activity.

Bravo-Santano N, Ellis JK, Calle Y, Keun HC, Behrends V, Letek M.

Metabolites. 2019 Jul 20;9(7). pii: E148. doi: 10.3390/metabo9070148.

5.

Host-directed kinase inhibitors act as novel therapies against intracellular Staphylococcus aureus.

Bravo-Santano N, Stölting H, Cooper F, Bileckaja N, Majstorovic A, Ihle N, Mateos LM, Calle Y, Behrends V, Letek M.

Sci Rep. 2019 Mar 19;9(1):4876. doi: 10.1038/s41598-019-41260-8.

6.

Acetaminophen cytotoxicity in HepG2 cells is associated with a decoupling of glycolysis from the TCA cycle, loss of NADPH production, and suppression of anabolism.

Behrends V, Giskeødegård GF, Bravo-Santano N, Letek M, Keun HC.

Arch Toxicol. 2019 Feb;93(2):341-353. doi: 10.1007/s00204-018-2371-0. Epub 2018 Dec 14.

7.

Intracellular Staphylococcus aureus Modulates Host Central Carbon Metabolism To Activate Autophagy.

Bravo-Santano N, Ellis JK, Mateos LM, Calle Y, Keun HC, Behrends V, Letek M.

mSphere. 2018 Aug 8;3(4). pii: e00374-18. doi: 10.1128/mSphere.00374-18.

Supplemental Content

Loading ...
Support Center